华大基因 (300676)
BGI Genomics Co., Ltd.
K-Line Chart
No K-line data available
Company NameShenzhen BGI Genomics Co., Ltd.
Listing Date2017-07-14
Issue Price13.64RMB
Registered Capital41831.707510k RMB
Legal RepresentativeZhao Lijian
Registered AddressUnit 1-1, 8th Floor South, Building B, BGI Time-Space Center, No. 9 Yunhua Road, Binhai Community, Meisha Street, Yantian District, Shenzhen
IndustryMedical Services
Main BusinessThrough multi-omics big data technologies such as genetic testing, mass spectrometry testing, and bioinformatics analysis, the company provides research services and comprehensive precision medicine testing solutions for scientific research institutions, enterprises and public institutions, medical institutions, and social health organizations.
Company ProfileBGI Genomics' main business is to provide genomic diagnostics and research services for medical institutions, scientific research institutions, enterprises and public institutions through means such as genetic testing. It serves domestic and international research universities, institutes, independent laboratories, pharmaceutical companies, and other organizations. Currently, the company has covered over 100 countries and regions worldwide, including more than 2,000 scientific research institutions and over 2,300 medical institutions in 32 provinces, municipalities, and autonomous regions in China, of which more than 300 are top-tier (Grade III, Class A) hospitals; it collaborates with over 3,000 overseas medical and scientific research institutions in regions such as Europe, the Americas, and Oceania.
Stock Details
1. Key Indicators
- Total Shares(W): 41831.71
- Circulating A-Shares(W): 41604.65
- Earnings Per Share(RMB): -0.0514
- Net Assets Per Share(RMB): 22.0919
- Operating Revenue(W RMB): 267363.87
- Total Profit(W RMB): -4602.23
- Net Profit Attributable to Parent(W RMB): -2138.70
- Net Profit Growth Rate(%): 82.78
- Weighted Return on Equity(%): -0.2300
- Operating Cash Flow Per Share(RMB): -1.0440
- Undistributed Profit Per Share(RMB): 8.7310
- Capital Reserve Per Share(RMB): 11.6676
2. Main Business
The main business covers:
- Providing research services to scientific research institutions, enterprises, medical institutions, and social health organizations.
- Providing comprehensive solutions for precision medical testing.
- Providing health management services.
3. Company Basic Information
- Company Name: BGI Genomics Co., Ltd.
- Listing Date: 2017-07-14
- Industry: Medicine & Healthcare - Medical Services (Tongdaxin Research Industry) / Professional Technical Services (CSRC Industry)
- Address: 8th Floor, Block B, BGI Time Center, No. 9 Yunhua Road, Meisha Street, Yantian District, Shenzhen, Guangdong, China
- Website: www.bgi.com
- Company Profile: The company's predecessor, BGI Medicine, was established on July 9, 2010, jointly funded by BGI Holdings and BGI Sanshengyuan (formerly BGI Agriculture). At its establishment, BGI Medicine had a registered capital of RMB 10 million, of which BGI Holdings contributed RMB 9.5 million in cash, accounting for 95% of the registered capital, and BGI Sanshengyuan contributed RMB 500,000 in cash, accounting for 5%. The initial capital contribution was RMB 1.9 million from BGI Holdings and RMB 100,000 from BGI Sanshengyuan, with the remaining capital to be paid within two years after the establishment of BGI Medicine. On July 7, 2010, Shenzhen Yongxin Ruihe Certified Public Accountants issued the "Capital Verification Report" (Shen Yongxin Hui Yan Zi [2010] No. 198), verifying that as of July 6, 2010, BGI Medicine had received the first installment of the registered capital totaling RMB 2 million, of which BGI Sanshengyuan contributed RMB 100,000 in cash and BGI Holdings contributed RMB 1.9 million in cash. On July 9, 2010, the Shenzhen Market Supervision Administration issued the "Business License" to the company, with registration number 440301104800923.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Shenzhen BGI Technology Co., Ltd. | General Legal Person | 12455.29 | 29.94 |
| 2 | Shenzhen Shenghua Investment Enterprise (Limited Partnership) | General Legal Person | 2976.52 | 7.15 |
| 3 | Huabao CSI Medical ETF | Fund | 710.98 | 1.71 |
| 4 | E Fund ChiNext ETF | Fund | 529.57 | 1.27 |
| 5 | Shenzhen BGI Sanshengyuan Technology Co., Ltd. | General Legal Person | 393.58 | 0.95 |
| 6 | CSI 500 ETF | Fund | 374.11 | 0.90 |
| 7 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 260.59 | 0.63 |
| 8 | Shenzhen BGI Genomics Co., Ltd. - Second Phase Employee Stock Ownership Plan | Asset Management Plan | 199.82 | 0.48 |
| 9 | UBS AG | QFII | 193.67 | 0.47 |
| 10 | ChinaAMC Panyi One-Year Regular Open Hybrid Securities Investment Fund | Fund | 46.00 | 0.11 |
5. Concept Sectors
- Venture Capital
- Infant & Child Concept
- Belt and Road Initiative
- Gene Concept
- Blockchain
- Big Data
- Assisted Reproduction
- Hepatitis Concept
- Data Elements
- Synthetic Biology
- AI Healthcare
- Margin Trading & Securities Lending
- QFII Heavy Holdings
- Consecutive Losses
- ChiNext Index
- SZSE 300 Index
- ChiNext 300 Index
- ChiNext Medicine Index
- Blockchain 50 Index
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information